Jakavi (05 mg, 10 mg, 15 mg, 20 mg.): Check Drug Details and Specifications

Indication

JAKAVI is used  to treat people with an enlarged spleen and other symptoms of myelofibrosis, a rare type of blood cancer & for the treatment for Non-small cell lung cancer & Pancreatic cancer.

.

Note

Precaution

         Stop taking Roxolitinib and seek immediate medical attention if any of the following occur:

• signs of bleeding in the brain (e.g., sudden altered level of consciousness, persistent headache, numbness, tingling, weakness, or paralysis)

• signs of bleeding in the stomach or intestine (e.g., passing black or bloodstained stools, or vomiting blood)
• signs of a serious allergic reaction (e.g., abdominal cramps, hives, difficulty breathing, nausea and vomiting, or swelling of the face and throat).